Value of Electrothermal Denervation during Arthroscopic Debridement of Anterior Ankle Impingement – A Prospective Randomised Study
- Conditions
- Impingement syndrome of the ankle jointNonspecific ankle pain
- Registration Number
- DRKS00025703
- Lead Sponsor
- BG Unfallklinik Frankfurt am Main
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 58
Isolated impingement of the ankle joint
- Minimum age 18 years
- General operability given
- Ability to give informed consent given (§ 40 Para. 1 Sentence 1 No. 3 AMG)
- Written informed consent for participation in the study is available
- Isolated arthroscopy of the upper ankle joint with debridement and electrothermal denervation without additional intervention
- Inclusion criteria not met
- Generalized arthrofibrosis
- Known coagulation disorder
- Known increased risk of thromboembolism
- Chronic pain that is not due to the ankle joint to be operated on BMI > 35 (obesity grade I)
- Patients with chronic painkiller abuse
- Higher grade (> 2°) insufficiency of the fibular ligament structures and deltoid ligament
- High-grade (> 2° large-surface, >3° small-surface) arthritic changes of the tibial and talar articular surface
- Necessity of peri-/postoperative analgesia by means of pain catheters
- Extension of intervention (e.g. cartilage repair), switch to open procedure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary target: 48-h postoperative VAS score (visual analog scale pain).
- Secondary Outcome Measures
Name Time Method Evaluation of secondary outcome measures such as redon's suction drainage delivery rate 24h postoperatively, range of motion, AOFAS-AH scores, the FFI, and the VAS FA each before and 6 weeks after surgery.